endocrinology
Bone health

Burden of low-dose bisphosphonate osteonecrosis revealed

Low dose bisphosphonates are responsible for half  the cases of osteonecrosis of the jaw seen by oral surgeons, and the number of patients affected is rising, figures from Queensland show. An audit of three Queensland public hospital found that 32 of the 61 patients admitted with the condition between 2003 and 2015 had been using ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic